# Lactoferrin for COVID-19-Induced Taste or Smell Abnormality

> **NCT05760079** · NA · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Covid19
- Taste Disorder, Secondary
- Taste Disorders
- Dysgeusia
- Smell Disorder
- Ageusia
- Anosmia

## Interventions

- **DIETARY_SUPPLEMENT:** Lactoferrin

## Key facts

- **NCT ID:** NCT05760079
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-06
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** difficult to coordinate between all of the different support systems needed across various departments
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05760079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05760079, "Lactoferrin for COVID-19-Induced Taste or Smell Abnormality". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05760079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*